WELL Health Technologies Corp, 375 Water Street Suite 550, Vancouver, BC (2025)

11/13/2025

WELL is pleased to provide a corporate update on its majority-owned platform subsidiary, Wellstar, including recent developments related to OceanMD's eReferral platform, recent strategic acquisitions, and the completion of a $62 million Series B financing round. Please see key highlights below.

📌 WELLSTAR's OceanMD has been awarded a material eReferral contract with a Canadian province following a competitive procurement process.

📌 WELLSTAR’s OceanMD is Canada’s eReferral market leader with programs in four Canadian provinces now facilitating over 1.7 million eReferrals annually nationwide with participation from more than 20,000 physicians and 3,800 clinics.

📌 WELLSTAR has signed three M&A-related transactions in November, including leading-edge Ambient AI Scribe Mutuo and two others within the Company’s billing unit.

📌 WELLSTAR recently released its Q3 financials, which demonstrated accelerated organic growth of 26% with overall YoY revenue growth of 67%.

📌 On October 31, 2025, WELLSTAR announced that it had executed an agreement with a leading group of institutional investors to raise $62 million to execute on growth opportunities. WELLSTAR has added a new member to its corporate development team and is aggressively pursuing its M&A pipeline.

To learn more, please follow the link below. 🔗

https://ow.ly/YHhw50Xrh89

11/10/2025

We’re excited to share that Eva Fong, Chief Financial Officer at WELL Health, has been named a C-Suite Awards winner by Business in Vancouver. This honour is a reflection of Eva’s dedication and work ethic!

The BIV feature on Eva highlighted her outstanding career accomplishment, having overseen more than 100 mergers and acquisitions, sometimes at the rate of one per month. Her leadership has been essential to WELL’s growth, leading the company from about $2 million in early revenue to over $1 billion in annual run rate today.

Congratulations to Eva for her remarkable achievement, impact on WELL, and the healthcare industry. Read the full article below. 🚀

https://ow.ly/Xu0650XpIXy

11/06/2025

WELL is pleased to announce its interim consolidated financial results for the quarter ended September 30, 2025. Please see key highlights below.

📌 WELL achieved record quarterly revenues of $364.6 million in Q3-2025, an increase of 56% compared to Q3-2024.

📌 WELL achieved record Adjusted EBITDA of $59.9 million in Q3-2025, an increase of 296% compared to $15.1 million in Q3-2024.

📌 Canadian Patient Services revenue and Adjusted EBITDA was $110.1 million and $14.1 million respectively in Q3-2025, an increase of 41% and 47%.

📌 WELL’s majority owned subsidiary, WELLSTAR Technologies Corp. announced a financing for $62 million at a 50% increase in share price relative to its prior December 2024 financing.

📌 WELL reaffirms its previously provided guidance for annual revenue between $1.40 billion to $1.45 billion with Adjusted EBITDA between $190 million to $210 million.

Hamed Shahbazi, Chairman and CEO of WELL commented, “We had an excellent quarter driven by strong performance network–wide but especially in our core Canadian businesses. We’re seeing our technology enabled approach, which is increasingly AI–enabled, drive real business results across the enterprise."

To read the full news release, follow the link below.

https://ow.ly/PWFq50XnJ8X

11/03/2025

We are proud to announce that Hamed Shahbazi, Founder, Chairman, and CEO of WELL Health, has been named TSX Technology Executive of the Year at the 2024–2025 Cantech Letter Awards, held during the 2025 Cantech Investment Conference in Toronto on October 9.

This award celebrates Hamed's visionary leadership in Canadian healthcare and recognizes the commitment of both the larger WELL Health team and the Providers who provide patient care every day.

Learn more at the link below!

https://ow.ly/u6h350XlZvv

10/31/2025

WELL is pleased to announce its majority-owned subsidiary Wellstar has entered into agreements to complete a Series B preferred share investment in the aggregate amount of approximately C$62 million at an offering price of C$1.50 per Series B Share. Please read the key highlights below.

📌 WELLSTAR enters into subscription agreements to complete a C$62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Managemen, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.

📌 The financing is anticipated to close early December, subject to certain closing conditions.

📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40,000 providers across Canada with high quality technology and services that significantly improve patient care.

To learn more details, follow the link below. 🔗

https://ow.ly/w3pT50Xl60K

10/23/2025

WELL will release Fiscal Third Quarter 2025 results before the market opens on Thursday, November 6, 2025. A conference call and webcast will follow at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time), hosted by Hamed Shahbazi, Chairman and Chief Executive Officer, and Eva Fong, Chief Financial Officer. We welcome everyone to join us!

Follow the link below for webcast details.

https://ow.ly/UkQk50Xh323

10/03/2025

Cantech Letter has published a feature article based on a research note by Stifel analyst Justin Keywood that suggests investors revisit WELL Health (TSX: WELL) as a result of recent transactions and the early consolidation trend of Canadian healthcare assets.

The article suggests that WELL may be undervalued as Stifel maintains its “Buy” rating with a $9 target price, noting the company's strong growth strategy through clinic acquisitions and digital transformation. The article further highlights upcoming catalysts, including continued M&A of Canadian clinics, margin expansion, and the potential spin-out of its Wellstar digital SaaS platform.

Read the full article below.

https://ow.ly/yFzW50X5WKU

10/02/2025

In September, our Chief Financial Officer, Eva Fong, hosted WELLs annual “Ask the CFO Anything” lunch with seven interns. These second to fourth year students from the University of British Columbia, Queen's University, and University of Washington are pursuing studies in Finance, Business, Economics, and Artificial Intelligence Engineering - a mix of disciplines that reflects the breadth of skills required in modern digital healthcare.

Many have returned to their fall academic programs and continue contributing part-time, balancing rigorous coursework with meaningful professional contribution. 🚀

In that spirit, thank you, Eva, for creating space for open questions and candid dialogue. And thank you to our interns for the dedication, energy, and perspective you bring to WELL!

09/25/2025

WELL and Wellstar are pleased to announce their joint participation at the upcoming 2025 Cantech Investment Conference on Thursday, October 9, 2025, in Toronto, Ontario.

At the conference, Hamed Shahbazi, Founder & CEO of WELL, will discuss our capital-efficient growth strategy and the continued momentum across our business, while Amir Javidan, CEO of WELLSTAR, will introduce WELLSTAR to the investment community, showcasing its technological capabilities and financial performance.

Together, their presentations will underscore the complementary strengths of WELL and WELLSTAR in delivering significant improvements for providers and patients, and long-term value creation for shareholders.

Location: Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON
WELL: 1:30 PM EST | WELLSTAR: 4:00 PM EST

🔗 Learn more by following the link below.

https://ow.ly/J7hN50X2uFV

09/12/2025

We’re proud to share that WELL Health has been recognized as the 2nd fastest-growing company in British Columbia by Business in Vancouver! This follows our #1 ranking last year and is a true reflection of the incredible work of our team, partners, and providers in advancing technology-enabled healthcare.

A big congratulations to all of the inspiring companies recognized this year - we’re honoured to be among such great company. Thank you to Business in Vancouver for shining a spotlight on growth and innovation across our province. Together, we’re building a stronger business community and healthier future for all Canadians!

🔗 Follow the link below to learn more.

https://ow.ly/S7yr50WWb05

09/12/2025

WELL has been named a “Best Idea” in TD Cowen’s Canada Best Ideas 2025 report, with analyst David Kwan maintaining a Buy rating and a C$7.50 target price. 🚀

🔗 Read more by following the link below!

https://ow.ly/j7kG50WVx21

08/14/2025

WELL is pleased to announce its interim consolidated financial results for the quarter ended June 30, 2025.

Quarterly highlights:
✅ $356.7 million in revenue - an increase of 57% compared to Q2-2024.
✅ Record Adjusted EBITDA of $49.7 million in Q2-2025 - an increase of 231% compared to Q2-2024.
✅ 1.7 million patient visits in Q2-2025 - an increase of 21% compared to 1.4 million patient visits in Q2-2024.
🇨🇦 Over 1 million patient visits across its Canadian operations, a new quarterly milestone.

Hamed Shahbazi, Chairman and CEO of WELL commented, “I am very proud of our performance this quarter as it reflects a very significant milestone in our history with best-ever performances across most of our key financial metrics. We delivered record performances across Revenue, Adjusted EBITDA, Adjusted Net Income, and patient visits."

🔗 Read the full release below!

https://ow.ly/mXFL50WFWkq

WELL Health Technologies Corp

11/13/2025

11/10/2025

11/06/2025

11/03/2025

10/31/2025

10/23/2025

10/03/2025

10/02/2025

09/25/2025

09/12/2025

09/12/2025

08/14/2025

Address

Website

Alerts

Shortcuts

Share

Category